Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy
Randomized Controlled Trial of Pediatric CI Therapy
1 other identifier
interventional
52
1 country
1
Brief Summary
Pediatric Constraint-Induced (CI) Movement therapy is a rehabilitation program designed to improve motor function in children with partial paralysis. Children with cerebral palsy may have one arm that has significantly greater function (good arm) than the other (bad arm). Restricting the use of the good arm may improve the use of the bad arm. In pediatric CI therapy, the good arm is put in a sling to force increased use of the bad arm. The bad arm is also trained each day for several weeks. This study will test the ability of pediatric CI therapy to improve motor function in children with cerebral palsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Sep 2002
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2002
CompletedFirst Submitted
Initial submission to the registry
May 21, 2003
CompletedFirst Posted
Study publicly available on registry
May 22, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2006
CompletedJune 24, 2005
April 1, 2003
May 21, 2003
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of hemiparetic cerebral palsy consistent with criteria in Swaiman and Russman (1999) and Badawi et al. (1998)
- Recommended for participation in pediatric rehabilitation and/or early intervention
- Lives within 50 miles of the Civitan Center at University of Alabama at Birmingham or the family is willing to temporarily relocate to the Birmingham area for treatment
You may not qualify if:
- Profound bilateral hearing loss with the use of hearing aids
- Severe visual impairment
- Serious seizure disorder or uncontrolled seizures
- Genetic and syndromic conditions historically excluded for CP registries
- Familial Spastic Paraplegia
- Ataxic Cerebral Palsy
- Diagnosis of Pervasive Developmental Disability or autism
- Serious or recurring medical complications
- Scheduled for surgery within 12 months of study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward Taub, PhD
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 21, 2003
First Posted
May 22, 2003
Study Start
September 1, 2002
Study Completion
September 1, 2006
Last Updated
June 24, 2005
Record last verified: 2003-04